SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001493152-20-020376
Filing Date
2020-11-03
Accepted
2020-11-03 14:20:35
Documents
1
Period of Report
2020-10-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 form8-ka.htm 8-K/A 40823
  Complete submission text file 0001493152-20-020376.txt   42243
Mailing Address 2 BEN GURION ST. B.S.R BUILDING#1, FLOOR#7, RAMAT GAN L3 5257334
Business Address 2 BEN GURION ST. B.S.R BUILDING#1, FLOOR#7, RAMAT GAN L3 5257334 972-72-2608004
OWC Pharmaceutical Research Corp. (Filer) CIK: 0001431934 (see all company filings)

IRS No.: 980573566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-54856 | Film No.: 201283054
SIC: 3841 Surgical & Medical Instruments & Apparatus